Netflix earnings beat expectations. Here's what analysts are saying

Investment Strategy Новости

Netflix earnings beat expectations. Here's what analysts are saying
Stock Markets,Netflix Inc,Business News

Analysts are getting even more bullish on Netflix following its earnings beat for the third quarter.

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 72%

Analysts are getting even more bullish on Netflix following its earnings beat for the third quarter . Shares jumped more than 6% in premarket trading Friday on the heels of the streamer's results. Earnings came in at $5.40 per share and revenue at $9.83 billion. That's well above Wall Street's estimates for the period, as analysts were expecting $5.12 per share on revenue of $9.77 billion, according to LSEG.

"It is abundantly clear that NFLX is demonstrating massive scale as it continues to produce strong subscriber results and free cash flow with the ability to invest to accelerate that growth while its streaming peers continue to generate substantial losses, are resorting to aggressive price hikes amidst generally mediocre subscriber results." Bernstein reiterates its market perform rating The firm increased its price target to $780 from $625.

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

CNBC /  🏆 12. in RU
 

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Analysts are getting more bullish on Netflix ahead of earningsAnalysts are getting more bullish on Netflix ahead of earningsA few analysts are upping their stance on the media giant ahead of its third-quarter earnings report next week.
Прочитайте больше »

Netflix Earnings Preview: Analysts Bullish Despite a Warning of Unrealistic ExpectationsNetflix Earnings Preview: Analysts Bullish Despite a Warning of Unrealistic ExpectationsSeveral finance experts have further raised their stock price targets, but at least one questioned if the stock has gotten ahead of itself given its gains so far this year.
Прочитайте больше »

These 9 biotech stocks have doubled this year and are set to double again, analysts sayThese 9 biotech stocks have doubled this year and are set to double again, analysts sayThe bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Прочитайте больше »

JPMorgan just refreshed its Analysts Focus List and added these 4 stocksJPMorgan just refreshed its Analysts Focus List and added these 4 stocksJPMorgan just refreshed its Analysts Focus List and added these 4 stocks
Прочитайте больше »



Render Time: 2025-01-14 00:37:56